Core Laboratories Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 6 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Core Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View analyst ratings for Core Laboratories or view top-rated stocks.

Wall Street analysts have given Core Laboratories a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Core Laboratories wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, October 20th 2021.
View our earnings forecast for Core Laboratories.

Core Laboratories (NYSE:CLB) posted its quarterly earnings data on Wednesday, July, 28th. The oil and gas company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.19 by $0.01. The oil and gas company earned $118.75 million during the quarter, compared to the consensus estimate of $118.85 million. Core Laboratories had a trailing twelve-month return on equity of 27.46% and a net margin of 7.32%.
View Core Laboratories' earnings history.

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CLB stock has increased by 140.0% and is now trading at $26.23.
View which stocks have been most impacted by COVID-19.

Core Laboratories announced a quarterly dividend on Friday, July 30th. Stockholders of record on Monday, August 9th will be given a dividend of $0.01 per share on Tuesday, August 24th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date is Friday, August 6th.
View Core Laboratories' dividend history.

Core Laboratories pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.15%. Core Laboratories does not yet have a strong track record of dividend growth. The dividend payout ratio of Core Laboratories is 5.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 3.36% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

Core Laboratories updated its third quarter 2021 earnings guidance on Wednesday, August, 4th. The company provided earnings per share guidance of $0.190-$0.210 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.230. The company issued revenue guidance of $122 million-$126 million, compared to the consensus revenue estimate of $125.67 million.

8 equities research analysts have issued 1-year target prices for Core Laboratories' shares. Their forecasts range from $17.50 to $37.00. On average, they expect Core Laboratories' share price to reach $26.42 in the next twelve months. This suggests a possible upside of 0.7% from the stock's current price.
View analysts' price targets for Core Laboratories or view top-rated stocks among Wall Street analysts.

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), Liberty Oilfield Services (LBRT), Oceaneering International (OII), National Energy Services Reunited (NESR), NexTier Oilfield Solutions (NEX), RPC (RES), ProPetro (PUMP), Frank's International (FI), Select Energy Services (WTTR), Helix Energy Solutions Group (HLX), North American Construction Group (NOA), FTS International (FTSI), Ranger Energy Services (RNGR), Natural Gas Services Group (NGS) and Mammoth Energy Services (TUSK).
View all of CLB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.45%), Vanguard Group Inc. (10.68%), Ariel Investments LLC (7.73%), Massachusetts Financial Services Co. MA (5.40%), Van ECK Associates Corp (4.45%) and Clearbridge Investments LLC (3.48%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Edgestream Partners L.P., Ariel Investments LLC, BlackRock Inc., Clearbridge Investments LLC, Fisher Asset Management LLC, Mairs & Power Inc., and Bank of New York Mellon Corp.
View insider buying and selling activity for Core Laboratories or view top insider-selling stocks.

CLB stock was purchased by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Morgan Stanley, Morgan Stanley, AKO Capital LLP, Confluence Investment Management LLC, Vanguard Group Inc., Invesco Ltd., and Amundi. Company insiders that have bought Core Laboratories stock in the last two years include Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories or or view top insider-buying stocks.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLB stock can currently be purchased for approximately $26.23.

Core Laboratories has a market capitalization of $1.22 billion and generates $487.27 million in revenue each year. The oil and gas company earns $-97,640,000.00 in net income (profit) each year or $0.80 on an earnings per share basis.

Core Laboratories employs 3,700 workers across the globe.

Core Laboratories was founded in 1936.

The official website for Core Laboratories is www.corelab.com.

Core Laboratories is headquartered at STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at (120) 420-3191 or via email at [email protected].